Patents/Assignees

Vertex Pharmaceuticals Incorporated

103 patents in portfolio

US11801234utility2023
Methods of Treating APOL-1 Dependent Focal Segmental Glomerulosclerosis
0 cites
US11801313utility2023
Materials and Methods for Treatment of Pain Related Disorders
0 cites
US11773119utility2023
Prodrugs of Pyridone Amides Useful as Modulators of Sodium Channels
0 cites
US11752106utility2023
Pharmaceutical Composition and Administrations Thereof
0 cites
US11708331utility2023
Processes for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
0 cites
US11673864utility2023
Pyridone Amides as Modulators of Sodium Channels
0 cites
US11639347utility2023
Modulators of Atp-binding Cassette Transporters
0 cites
USRE049500reissue2023
Pyrrole Inhibitors of ERK Protein Kinase, Synthesis Thereof and Intermediates Thereto
0 cites
US11634447utility2023
Mannose Derivatives for Treating Bacterial Infections
0 cites
US11623924utility2023
Modulators of Alpha-1 Antitrypsin
0 cites
US11618746utility2023
Inhibitors of APOL1 and Methods of Using Same
0 cites
US11613744utility2023
Modified Urokinase-type Plasminogen Activator Polypeptides and Methods of Use
0 cites
US11603351utility2023
Carboxamides as Modulators of Sodium Channels
0 cites
US11591350utility2023
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
0 cites
US11584761utility2023
Process of Making CFTR Modulators
0 cites
US11578062utility2023
Solid Forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide
0 cites
US11572364utility2023
Pteridinone Compounds and Uses Thereof
0 cites
US11564916utility2023
Pharmaceutical Composition and Administrations Thereof
0 cites
US11566236utility2023
Materials and Methods for Treatment of Hemoglobinopathies
0 cites
US8343763utility2013
Heterocyclic Derivatives as Modulators of Ion Channels
0 cites

← PreviousPage 5 of 6Next →